Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
Br J Surg ; 108(11): 1351-1359, 2021 11 11.
Article in English | MEDLINE | ID: covidwho-1393168

ABSTRACT

BACKGROUND: Uncomplicated acute appendicitis can be managed with non-operative (antibiotic) treatment, but laparoscopic appendicectomy remains the first-line management in the UK. During the COVID-19 pandemic the practice altered, with more patients offered antibiotics as treatment. A large-scale observational study was designed comparing operative and non-operative management of appendicitis. The aim of this study was to evaluate 90-day follow-up. METHODS: A prospective, cohort study at 97 sites in the UK and Republic of Ireland included adult patients with a clinical or radiological diagnosis of appendicitis that either had surgery or non-operative management. Propensity score matching was conducted using age, sex, BMI, frailty, co-morbidity, Adult Appendicitis Score and C-reactive protein. Outcomes were 90-day treatment failure in the non-operative group, and in the matched groups 30-day complications, length of hospital stay (LOS) and total healthcare costs associated with each treatment. RESULTS: A total of 3420 patients were recorded: 1402 (41 per cent) had initial antibiotic management and 2018 (59 per cent) had appendicectomy. At 90-day follow-up, antibiotics were successful in 80 per cent (1116) of cases. After propensity score matching (2444 patients), fewer overall complications (OR 0.36 (95 per cent c.i. 0.26 to 0.50)) and a shorter median LOS (2.5 versus 3 days, P < 0.001) were noted in the antibiotic management group. Accounting for interval appendicectomy rates, the mean total cost was €1034 lower per patient managed without surgery. CONCLUSION: This study found that antibiotics is an alternative first-line treatment for adult acute appendicitis and can lead to cost reductions.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Appendicitis/therapy , Adult , Appendectomy/statistics & numerical data , Appendicitis/economics , Cohort Studies , Female , Follow-Up Studies , Humans , Ireland , Length of Stay/statistics & numerical data , Male , Matched-Pair Analysis , Middle Aged , United Kingdom
2.
Eur J Pediatr Surg ; 31(4): 311-318, 2021 Aug.
Article in English | MEDLINE | ID: covidwho-1279929

ABSTRACT

The fast-evolving nature of the coronavirus disease 2019 (COVID-19) pandemic has led to unprecedented clinical, logistical, and socioeconomical challenges for health-care systems worldwide. While several studies have analyzed the impact on the presentation and management of acute appendicitis (AA) in the adult population, there is a relative paucity of similar research in pediatric patients with AA. To date, there is some evidence that the incidence of simple AA in children may have decreased during the first lockdown period in spring 2020, whereas the number of complicated AA cases remained unchanged or increased slightly. Despite a worrying trend toward delayed presentation, most pediatric patients with AA were treated expediently during this time with comparable outcomes to previous years. Hospitals must consider their individual capacity and medical resources when choosing between operative and non-operative management of children with AA. Testing for severe acute respiratory syndrome coronavirus type 2 is imperative in all pediatric patients presenting with fever and acute abdominal pain with diarrhea or vomiting, to differentiate between multisystem inflammatory syndrome and AA, thus avoiding unnecessary surgery. During the further extension of the COVID-19 crisis, parents should be encouraged to seek medical care with their children early in order that the appropriate treatment for AA can be undertaken in a timely fashion.


Subject(s)
Appendicitis , COVID-19 , Abdominal Pain , Appendicitis/diagnosis , Appendicitis/epidemiology , Appendicitis/therapy , COVID-19/diagnosis , Child , Diagnosis, Differential , Diarrhea , Humans , Incidence , Length of Stay , Pandemics , Postoperative Complications/epidemiology , Symptom Assessment , Systemic Inflammatory Response Syndrome/diagnosis , Vomiting
3.
Cir Esp (Engl Ed) ; 99(6): 450-456, 2021.
Article in English | MEDLINE | ID: covidwho-1258347

ABSTRACT

INTRODUCTION: The COVID-19 pandemic has had a significant impact on Spanish hospitals, which have had to allocate all available resources to treat these patients, reducing the ability to attend other common pathologies. The aim of this study is to analyze how the treatment of acute appendicitis has been affected. METHOD: A national descriptive study was carried out by an online voluntary specific questionnaire with Google Drive™ distributed by email by the Spanish Association of Surgeons (AEC) to all affiliated surgeons currently working in Spain (5203), opened from April 14th to April 24th. RESULTS: We received 337 responses from 170 centers. During the first month of the pandemic, the incidence of acute appendicitis decreased. Although conservative management increased, the surgical option has been the most used in both simple and complicated appendicitis. Despite the fact that the laparoscopic approach continues to be the most widely used in our services, the open approach has increased during this pandemic period. CONCLUSION: Highlight the contribution of this study in terms of knowledge of the status of the treatment of acute appendicitis during this first month of the pandemic, being able to serve for a better possible organization in future waves of the pandemic and a reorganization of current protocols and management of acute appendicitis in a pandemic situation.


Subject(s)
Appendectomy/trends , Appendicitis/therapy , COVID-19/therapy , Conservative Treatment/trends , Health Care Rationing/trends , Infection Control/trends , Practice Patterns, Physicians'/trends , Acute Disease , Appendectomy/methods , Appendicitis/complications , Appendicitis/diagnosis , Appendicitis/epidemiology , COVID-19/complications , COVID-19/diagnosis , COVID-19/epidemiology , Health Care Surveys , Humans , Incidence , Infection Control/methods , Laparoscopy/trends , Pandemics , Spain/epidemiology
4.
CMAJ ; 193(21): E753-E760, 2021 05 25.
Article in English | MEDLINE | ID: covidwho-1243856

ABSTRACT

BACKGROUND: Reduced use of the emergency department during the COVID-19 pandemic may result in increased disease acuity when patients do seek health care services. We sought to evaluate emergency department visits for common abdominal and gynecologic conditions before and at the beginning of the pandemic to determine whether changes in emergency department attendance had serious consequences for patients. METHODS: We conducted a population-based analysis using administrative data to evaluate the weekly rate of emergency department visits pre-COVID-19 (Jan. 1-Mar. 10, 2020) and during the beginning of the COVID-19 pandemic (Mar. 11-June 30, 2020), compared with a historical control period (Jan. 1-July 1, 2019). All residents of Ontario, Canada, presenting to the emergency department with appendicitis, cholecystitis, ectopic pregnancy or miscarriage were included. We evaluated weekly incidence rate ratios (IRRs) of emergency department visits, management strategies and clinical outcomes. RESULTS: Across all study periods, 39 691 emergency department visits met inclusion criteria (40.2 % appendicitis, 32.1% miscarriage, 21.3% cholecystitis, 6.4% ectopic pregnancy). Baseline characteristics of patients presenting to the emergency department did not vary across study periods. After an initial reduction in emergency department visits, presentations for cholecystitis and ectopic pregnancy quickly returned to expected levels. However, presentations for appendicitis and miscarriage showed sustained reductions (IRR 0.61-0.80), with 1087 and 984 fewer visits, respectively, after the start of the pandemic, relative to 2019. Management strategies, complications and mortality rates were similar across study periods for all conditions. INTERPRETATION: Although our study showed evidence of emergency department avoidance in Ontario during the first wave of the COVID-19 pandemic, no adverse consequences were evident. Emergency care and outcomes for patients were similar before and during the pandemic.


Subject(s)
Appendicitis , COVID-19 , Cholecystitis , Emergency Service, Hospital/trends , Facilities and Services Utilization/trends , Genital Diseases, Female , Patient Acceptance of Health Care/statistics & numerical data , Abortion, Spontaneous/diagnosis , Abortion, Spontaneous/epidemiology , Abortion, Spontaneous/therapy , Adult , Aged , Appendicitis/diagnosis , Appendicitis/epidemiology , Appendicitis/therapy , COVID-19/epidemiology , COVID-19/psychology , Cholecystitis/diagnosis , Cholecystitis/epidemiology , Cholecystitis/therapy , Cross-Sectional Studies , Female , Genital Diseases, Female/diagnosis , Genital Diseases, Female/epidemiology , Genital Diseases, Female/therapy , Humans , Male , Middle Aged , Ontario/epidemiology , Pandemics , Pregnancy , Pregnancy, Ectopic/diagnosis , Pregnancy, Ectopic/epidemiology , Pregnancy, Ectopic/therapy , Severity of Illness Index
5.
Br J Hosp Med (Lond) ; 82(3): 1-6, 2021 Mar 02.
Article in English | MEDLINE | ID: covidwho-1168179

ABSTRACT

Antibiotics are one of the most widely used classes of drugs within hospitals in the UK. They have a wide range of uses within all surgical specialties, both as preoperative prophylaxis and for treatment of acute surgical conditions. Antimicrobial resistance has increasingly been seen as a major issue, as the production of new antibiotics has decreased and overall use worldwide has increased. With the COVID-19 pandemic increasing concerns about antimicrobial resistance, there is an ever-increasing need for action. This article examines the particular challenges of antibiotic stewardship in surgical departments within the UK, and outlines possible solutions for improving adherence and reducing the risk of antimicrobial resistance in the future.


Subject(s)
Antibiotic Prophylaxis/methods , Antimicrobial Stewardship/methods , Surgery Department, Hospital , Surgical Wound Infection/prevention & control , Appendicitis/therapy , Cholecystitis/therapy , Diverticulitis/therapy , Humans , Preoperative Care , Surgical Wound Infection/drug therapy , United Kingdom
6.
J Coll Physicians Surg Pak ; 30(1): S50-S54, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-1112952

ABSTRACT

OBJECTIVE: To measure the outcomes of conservative treatment of acute appendicitis. STUDY DESIGN: Observational study. PLACE AND DURATION OF STUDY: Fauji Foundation Hospital, Rawalpindi from April to July 2020.  Methodology: All 58 patients (n=58) presenting with acute appendicitis (AA) were included. Assessment was done with Alvarado score (AS) and ultrasound. Treatment was initiated according to the algorithm corresponding with AS. Those with AS score of 4 or less were started on outpatient oral antibiotics. Patients with AS score of 5 or more were admitted for IV antibiotics. If the symptoms and signs resolved, they were sent home on oral antibiotics to complete a course of 5 days. If their condition did not improve in 72 hours or deteriorated at any time, appendectomy was done. Outcomes were recorded and analysed on SPSS. RESULTS: Out of 58 patients, 16 were treated with oral, while 42 with IV antibiotics. This yielded a statistically significant difference on the course of disease (p=0.028). Resolution of symptoms was seen in 27.6% (n=16) with conservative management; whereas, 72.4% (n=42) patients needed a subsequent appendectomy. The difference in operative findings between patients, who had been given oral or IV antibiotics was statistically insignificant (p=0.536). Diagnostic value of leukocyte count (TLC), ultrasound and AS was not found to be significant. CONCLUSION: Non-operative management is successful in about a quarter of the patients of AA. There is very limited value of sonography, laboratory parameters, or AS in confirming the diagnosis of AA. Key Words: Appendicitis, Conservative treatmen, COVID-19.


Subject(s)
Appendicitis/therapy , COVID-19/epidemiology , Conservative Treatment/methods , Pandemics , Acute Disease , Adult , Appendicitis/epidemiology , Comorbidity , Female , Humans , Male , Middle Aged , Prospective Studies , Young Adult
8.
Langenbecks Arch Surg ; 406(2): 357-365, 2021 Mar.
Article in English | MEDLINE | ID: covidwho-917118

ABSTRACT

PURPOSE: The COVID-19 pandemic has reformed global healthcare delivery. On 25 March 2020, Intercollegiate guidelines were published in the UK to promote safe surgical provision during the COVID-19 outbreak advocating non-operative management or avoidance of laparoscopy when surgery is essential. The effects of this on the investigation and management of appendicitis remain unknown. METHODS: We performed a multicentre, prospective, observational study from the start of the new guidelines to the 6th of May 2020. We included all patients referred to surgical teams with suspected appendicitis. A recent historical cohort was identified for comparison. The primary outcome was the impact of the COVID-19 pandemic on the use of non-operative management in appendicitis. Secondary outcomes included imaging, negative appendicectomy rate (NAR), length of stay (LOS) and 30-day complications. RESULTS: A total of 63/164 (38%) patients compared to 79/191 (41%) were diagnosed with appendicitis before and after the guidelines were introduced (p = 0.589). CT scanning increased (71/164 vs 105/191; p = 0.033) while ultrasound scanning decreased (71/164 vs 62/191; p = 0.037). Appendicitis was more likely to be managed non-operatively (11/63 vs 51/79; p < 0.001) and, of those managed surgically, with an open approach (3/52 vs 26/28 p < 0.001). The NAR also reduced (5/52 vs 0/28; p = 0.157). LOS was shorter in non-operatively managed patients (1 day vs 3 days; p < 0.001) without a difference in complications (10/51 vs 4/28; p = 0.760). CONCLUSION: Introduction of the guidelines was associated with changes in practice. Despite these changes, short-term complications did not increase and LOS decreased. Questions remain on the longer-term complication rates in non-operatively managed patients.


Subject(s)
Appendicitis/diagnosis , Appendicitis/therapy , COVID-19/prevention & control , Postoperative Complications/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Appendectomy , Appendicitis/etiology , COVID-19/diagnosis , COVID-19/epidemiology , Cohort Studies , Female , Humans , Laparoscopy , Length of Stay , Male , Middle Aged , Tomography, X-Ray Computed , United Kingdom , Young Adult
9.
Br J Surg ; 108(6): 717-726, 2021 06 22.
Article in English | MEDLINE | ID: covidwho-837718

ABSTRACT

BACKGROUND: Surgical strategies are being adapted to face the COVID-19 pandemic. Recommendations on the management of acute appendicitis have been based on expert opinion, but very little evidence is available. This study addressed that dearth with a snapshot of worldwide approaches to appendicitis. METHODS: The Association of Italian Surgeons in Europe designed an online survey to assess the current attitude of surgeons globally regarding the management of patients with acute appendicitis during the pandemic. Questions were divided into baseline information, hospital organization and screening, personal protective equipment, management and surgical approach, and patient presentation before versus during the pandemic. RESULTS: Of 744 answers, 709 (from 66 countries) were complete and were included in the analysis. Most hospitals were treating both patients with and those without COVID. There was variation in screening indications and modality used, with chest X-ray plus molecular testing (PCR) being the commonest (19·8 per cent). Conservative management of complicated and uncomplicated appendicitis was used by 6·6 and 2·4 per cent respectively before, but 23·7 and 5·3 per cent, during the pandemic (both P < 0·001). One-third changed their approach from laparoscopic to open surgery owing to the popular (but evidence-lacking) advice from expert groups during the initial phase of the pandemic. No agreement on how to filter surgical smoke plume during laparoscopy was identified. There was an overall reduction in the number of patients admitted with appendicitis and one-third felt that patients who did present had more severe appendicitis than they usually observe. CONCLUSION: Conservative management of mild appendicitis has been possible during the pandemic. The fact that some surgeons switched to open appendicectomy may reflect the poor guidelines that emanated in the early phase of SARS-CoV-2.


ANTECEDENTES: Las estrategias quirúrgicas están siendo adaptadas en presencia de la pandemia de la COVID-19. Las recomendaciones del tratamiento de la apendicitis aguda se han basado en la opinión de expertos, pero hay muy poca evidencia disponible. Este estudio abordó este aspecto a través de una visión de los enfoques mundiales de la cirugía de la apendicitis. MÉTODOS: La Asociación de Cirujanos Italianos en Europa (ACIE) diseñó una encuesta electrónica en línea para evaluar la actitud actual de los cirujanos a nivel mundial con respecto al manejo de pacientes con apendicitis aguda durante la pandemia. Las preguntas se dividieron en información basal, organización del hospital y cribaje, equipo de protección personal, manejo y abordaje quirúrgico, así como las características de presentación del paciente antes y durante de la pandemia. Se utilizó una prueba de ji al cuadrado para las comparaciones. RESULTADOS: De 744 respuestas, se habían completado 709 (66 países) cuestionarios, los datos de los cuales se incluyeron en el estudio. La mayoría de los hospitales estaban tratando a pacientes con y sin COVID. Hubo variabilidad en las indicaciones de cribaje de la COVID-19 y en la modalidad utilizada, siendo la tomografía computarizada (CT) torácica y el análisis molecular (PCR) (18,1%) las pruebas utilizadas con más frecuencia. El tratamiento conservador de la apendicitis complicada y no complicada se utilizó en un 6,6% y un 2,4% antes de la pandemia frente a un 23,7% y un 5,3% durante la pandemia (P < 0.0001). Un tercio de los encuestados cambió la cirugía laparoscópica a cirugía abierta debido a las recomendaciones de los grupos de expertos (pero carente de evidencia científica) durante la fase inicial de la pandemia. No hubo acuerdo en cómo filtrar el humo generado por la laparoscopia. Hubo una reducción general del número de pacientes ingresados con apendicitis y un tercio consideró que los pacientes atendidos presentaban una apendicitis más grave que las comúnmente observadas. CONCLUSIÓN: La pandemia ha demostrado que ha sido posible el tratamiento conservador de la apendicitis leve. El hecho de que algunos cirujanos cambiaran a una apendicectomía abierta podría ser el reflejo de las pautas deficientes que se propusieron en la fase inicial del SARS-CoV2.


Subject(s)
Appendicitis/therapy , Attitude of Health Personnel , COVID-19 , Practice Patterns, Physicians'/statistics & numerical data , Surgeons , Anti-Bacterial Agents/therapeutic use , Appendectomy/methods , Appendectomy/statistics & numerical data , COVID-19 Testing/statistics & numerical data , Hospital Administration , Humans , Pandemics , Personal Protective Equipment/statistics & numerical data , Surveys and Questionnaires
10.
J Hosp Infect ; 106(4): 673-677, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-808779

ABSTRACT

We assessed infection control efforts by comparing data collected over 20 weeks during a pandemic under a dual-track healthcare system. A decline in non-COVID-19 patients visiting the emergency department by 37.6% (P<0.01) was observed since admitting COVID-19 cases. However, patients with acute myocardial infarction (AMI), stroke, severe trauma and acute appendicitis presenting for emergency care did not decrease. Door-to-balloon time (34.3 (± 11.3) min vs 22.7 (± 8.3) min) for AMI improved significantly (P<0.01) while door-to-needle time (55.7 (± 23.9) min vs 54.0 (± 18.0) min) in stroke management remained steady (P=0.80). Simultaneously, time-sensitive care involving other clinical services, including patients requiring chemotherapy, radiation therapy and haemodialysis did not change.


Subject(s)
COVID-19/epidemiology , Emergency Medical Services/statistics & numerical data , Hospitals/statistics & numerical data , Time-to-Treatment/statistics & numerical data , Acute Disease , Appendicitis/epidemiology , Appendicitis/therapy , COVID-19/diagnosis , COVID-19/transmission , COVID-19/virology , Cross-Sectional Studies , Emergency Service, Hospital/statistics & numerical data , Hospitalization/statistics & numerical data , Humans , Infection Control/organization & administration , Myocardial Infarction/epidemiology , Myocardial Infarction/therapy , Pandemics/prevention & control , SARS-CoV-2/genetics , Seoul/epidemiology , Stroke/epidemiology , Stroke/therapy , Time-to-Treatment/trends , Wounds and Injuries/epidemiology , Wounds and Injuries/therapy
15.
Rev Col Bras Cir ; 47: e20202614, 2020.
Article in Portuguese, English | MEDLINE | ID: covidwho-637265

ABSTRACT

In December 2019, in Wuhan, China, the first cases of what would be known as COVID-19, a disease caused by an RNA virus called SARS-CoV-2, were described. Its spread was rapid and wide, leading the World Health Organization to declare a pandemic in March 2020. The disease has distinct clinical presentations, from asymptomatic to critical cases, with high lethality. Parallel to this, patients with non-traumatic surgical emergencies, such as acute appendicitis and cholecystitis, continue to be treated at the emergency services. In this regard, there were several doubts on how to approach these cases, among them: how to quickly identify the patient with COVID-19, what is the impact of the abdominal surgical disease and its treatment on the evolution of patients with COVID-19, in addition to the discussion about the role of the non-operative treatment for abdominal disease under these circumstances. In this review, we discuss these problems based on the available evidence.


Subject(s)
Betacoronavirus , Coronavirus Infections/epidemiology , Gastrointestinal Diseases/therapy , Pneumonia, Viral/epidemiology , Acute Disease , Appendicitis/therapy , COVID-19 , Cholecystitis/therapy , Coronavirus Infections/diagnosis , Coronavirus Infections/transmission , Emergencies , Gastrointestinal Diseases/surgery , Health Personnel , Humans , Pandemics , Pneumonia, Viral/diagnosis , Pneumonia, Viral/transmission , Practice Guidelines as Topic , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL